Ovid Therapeutics Inc (OVID)

06:36 AM

How Ovid Therapeutics Inc. stock reacts to oil prices2026 world cup usa national team qualification goalkeepers low block defense knockout prediction statistical analysis - Улправда

06:36 AM

07:14 AM

Is Ovid Therapeutics Inc. stock positioned well for digital economy2026 world cup usa national team round of 32 defensive leaders low block defense group prediction preview - Улправда

07:14 AM

05:16 AM

2026 world cup fixtures tips: How Ovid Therapeutics Inc. stock performs in weak economy2026 world cup usa national team quarterfinals young talents pressing system tactical prediction guide - Улправда

05:16 AM

Dec 29, 2025

Ovid Therapeutics is a buy, this analyst says - Cantech Letter

Dec 29, 2025

Dec 27, 2025

Wall Street Zen Upgrades Ovid Therapeutics (NASDAQ:OVID) to "Hold" - MarketBeat

Dec 27, 2025

Dec 26, 2025

Ovid Therapeutics (STU:1OT) EV-to-FCF : -2.91 (As of Dec. 26, 2025) - GuruFocus

Dec 26, 2025

Dec 26, 2025

Ovid Therapeutics (STU:1OT) EV-to-OCF : -2.91 (As of Dec. 27, 2025) - GuruFocus

Dec 26, 2025

Dec 26, 2025

Promising Penny Stocks To Watch In December 2025 - simplywall.st

Dec 26, 2025

Dec 24, 2025

FY2025 Earnings Forecast for OVID Issued By Lifesci Capital - MarketBeat

Dec 24, 2025

Dec 22, 2025

LifeSci Capital Initiates Coverage of Ovid Therapeutics (OVID) with Outperform Recommendation - Nasdaq

Dec 22, 2025

Dec 22, 2025

Form 424B3 Ovid Therapeutics Inc. - StreetInsider

Dec 22, 2025

Dec 22, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Dec 22, 2025

Dec 22, 2025

Ovid Therapeutics (OVID) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 22, 2025

Dec 22, 2025

Ovid Therapeutics (NASDAQ:OVID) Earns Outperform Rating from Analysts at Lifesci Capital - MarketBeat

Dec 22, 2025

Dec 22, 2025

Ovid Therapeutics' (OVID) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Dec 22, 2025

Dec 22, 2025

OVID: HC Wainwright Reiterates Buy Rating with $2.00 Price Targe - GuruFocus

Dec 22, 2025

Dec 22, 2025

HC Wainwright & Co. Reiterates Ovid Therapeutics (OVID) Buy Recommendation - Nasdaq

Dec 22, 2025

Dec 21, 2025

Is Ovid Therapeutics Inc. stock undervalued vs historical averagesJuly 2025 Macro Moves & Safe Entry Trade Reports - Улправда

Dec 21, 2025

Dec 20, 2025

How Ovid Therapeutics Inc. (1OT) stock stacks up against competitorsWeekly Trade Report & Smart Investment Allocation Insights - Улправда

Dec 20, 2025

Dec 19, 2025

Will Ovid Therapeutics Inc. stock recover faster than peersGold Moves & Real-Time Volume Triggers - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Is Ovid Therapeutics Inc. stock a smart buy before Fed meetingWatch List & Safe Entry Trade Reports - Улправда

Dec 19, 2025

Dec 19, 2025

How Ovid Therapeutics Inc. stock performs in weak economyMarket Rally & Technical Confirmation Trade Alerts - Улправда

Dec 19, 2025

Dec 18, 2025

Takeda’s Zasocitinib Marks Another Win In Late-Stage Pipeline Strategy - Citeline News & Insights

Dec 18, 2025

Dec 18, 2025

Ovid’s KCC2 activator shows promising safety in early trial By Investing.com - Investing.com Nigeria

Dec 18, 2025

Dec 18, 2025

Ovid Therapeutics Advances Oral KCC2 Activators After OV350 Data - TipRanks

Dec 18, 2025

Dec 18, 2025

Ovid Therapeutics announces phase 1 results for Ov350 - marketscreener.com

Dec 18, 2025

Dec 18, 2025

Ovid Therapeutics Inc Reports Phase 1 Results for OV350 - TradingView — Track All Markets

Dec 18, 2025

Dec 18, 2025

Ovid’s KCC2 activator shows promising safety in early trial - Investing.com

Dec 18, 2025

Dec 18, 2025

Ovid Therapeutics Reports Phase 1 Results for the - GlobeNewswire

Dec 18, 2025

Dec 16, 2025

Ovid Therapeutics (NASDAQ:OVID) Receives Average Rating of "Buy" from Brokerages - MarketBeat

Dec 16, 2025

Dec 13, 2025

Aug Big Picture: How analysts rate Ovid Therapeutics Inc stock todayWeekly Loss Report & Technical Confirmation Alerts - moha.gov.vn

Dec 13, 2025

Dec 12, 2025

Janus Henderson Group PLC Acquires Significant Stake in Ovid The - GuruFocus

Dec 12, 2025

Dec 12, 2025

Roth Capital Initiates Coverage on Ovid Therapeutics (NASDAQ:OVID) - MarketBeat

Dec 12, 2025

Dec 11, 2025

Ovid Therapeutics shareholders approve increase in authorized shares and related proposals - Investing.com Canada

Dec 11, 2025

Dec 11, 2025

Ovid Therapeutics shareholders approve increase in authorized shares and related proposals By Investing.com - Investing.com South Africa

Dec 11, 2025

Dec 11, 2025

Ovid Therapeutics Stockholders Approve Key Proposals - TipRanks

Dec 11, 2025

Dec 11, 2025

Roth Capital Initiates Coverage of Ovid Therapeutics (OVID) with Buy Recommendation - Nasdaq

Dec 11, 2025

Dec 11, 2025

Roth/MKM initiates Ovid Therapeutics stock with Buy rating on epilepsy drug - Investing.com Canada

Dec 11, 2025

Dec 11, 2025

OVID: Roth Capital Initiates Coverage with a "Buy" Rating at $3. - GuruFocus

Dec 11, 2025

Dec 11, 2025

Roth Capital Initiates Ovid Therapeutics With Buy Rating, $3 Price Target - marketscreener.com

Dec 11, 2025

Dec 07, 2025

What analysts say about Ovid Therapeutics Inc stockTrading Volume Surges & Capitalize On Fast Trends - earlytimes.in

Dec 07, 2025

Dec 05, 2025

Will Ovid Therapeutics Inc. stock deliver long term returns - Newser

Dec 05, 2025

Dec 05, 2025

Will Ovid Therapeutics Inc. (1OT) stock see valuation expansionEarnings Recap Report & Low Risk High Win Rate Stock Picks - Newser

Dec 05, 2025

Dec 04, 2025

Will Ovid Therapeutics Inc. (1OT) stock gain from lower interest ratesPortfolio Performance Summary & Weekly Market Pulse Alerts - Newser

Dec 04, 2025

Dec 04, 2025

Minerva jumps on phase III funding, leading neuro stocks - BioWorld MedTech

Dec 04, 2025

Dec 04, 2025

Will Ovid Therapeutics Inc. stock gain from strong economyDividend Hike & Precise Entry and Exit Recommendations - Newser

Dec 04, 2025